163 related articles for article (PubMed ID: 25167795)
1. Clinicopathologic characteristics of interval gastric cancer in Korea.
Park MS; Yoon JY; Chung HS; Lee H; Park JC; Shin SK; Lee SK; Lee YC
Gut Liver; 2015 Mar; 9(2):166-73. PubMed ID: 25167795
[TBL] [Abstract][Full Text] [Related]
2. Natural history of gastric cancer from a retrospective review of endoscopic images of older patients with interval gastric cancer.
Iida T; Yamashita K; Ohwada S; Ohkubo Y; Hirano T; Miyake T; Onodera K; Kubo T; Yamano H; Nakase H
Geriatr Gerontol Int; 2018 Jul; 18(7):997-1002. PubMed ID: 29498489
[TBL] [Abstract][Full Text] [Related]
3. Missed esophageal and gastric cancers after esophagogastroduodenoscopy in a midwestern military veteran population.
Khalil Q; Gopalswamy N; Agrawal S
South Med J; 2014 Apr; 107(4):225-8. PubMed ID: 24937515
[TBL] [Abstract][Full Text] [Related]
4. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis.
Pimenta-Melo AR; Monteiro-Soares M; Libânio D; Dinis-Ribeiro M
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1041-9. PubMed ID: 27148773
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer missed at esophagogastroduodenoscopy in a well-defined Spanish population.
Delgado Guillena PG; Morales Alvarado VJ; Jimeno Ramiro M; Rigau Cañardo J; Ramírez Salazar C; García Rodríguez A; Córdova Guevara H; Fernández Esparrach G
Dig Liver Dis; 2019 Aug; 51(8):1123-1129. PubMed ID: 30967337
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees.
Nam SY; Choi IJ; Park KW; Kim CG; Lee JY; Kook MC; Lee JS; Park SR; Lee JH; Ryu KW; Kim YW
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):855-60. PubMed ID: 19369882
[TBL] [Abstract][Full Text] [Related]
7. Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea.
Lim SB; Jeong SY; Choi HS; Sohn DK; Hong CW; Jung KH; Chang HJ; Park JG; Choi IJ; Kim CG
Int J Colorectal Dis; 2008 Jan; 23(1):61-5. PubMed ID: 17724601
[TBL] [Abstract][Full Text] [Related]
8. Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy.
Park JM; Huo SM; Lee HH; Lee BI; Song HJ; Choi MG
Gastroenterology; 2017 Aug; 153(2):460-469.e1. PubMed ID: 28501581
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic predictors for undifferentiated histology in differentiated gastric neoplasms prior to endoscopic resection.
Choi JM; Kim SG; Yang HJ; Lim JH; Choi J; Im JP; Kim JS; Kim WH; Jung HC
Surg Endosc; 2016 Jan; 30(1):89-98. PubMed ID: 25814072
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of microsatellite instability in interval gastric cancers.
Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ; Han HS
Dig Dis Sci; 2014 Feb; 59(2):322-7. PubMed ID: 24357187
[TBL] [Abstract][Full Text] [Related]
11. Rate and Predictors of Interval Esophageal and Gastric Cancers after Esophagogastroduodenoscopy in the United States.
Wang YR; Loftus EV; Judge TA; Peikin SR
Digestion; 2016; 94(3):176-180. PubMed ID: 27871069
[TBL] [Abstract][Full Text] [Related]
12. Should every region use the same gastric cancer scanning and treatment approaches? let's reconsider: a northeastern turkey example.
Fatih A; Yasin O; Hakan D; Yavuz A
BMC Gastroenterol; 2016 Oct; 16(1):120. PubMed ID: 27716069
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening.
Park CH; Kim B; Chung H; Lee H; Park JC; Shin SK; Lee SK; Lee YC
Dig Dis Sci; 2015 Jan; 60(1):38-46. PubMed ID: 25063206
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Cimetropium Bromide Use for the Detection of Gastric Neoplasms During Esophagogastroduodenoscopy.
Kim SY; Park JM; Cho HS; Cho YK; Choi MG
JAMA Netw Open; 2022 Mar; 5(3):e223827. PubMed ID: 35319761
[TBL] [Abstract][Full Text] [Related]
15. A cohort study of missed and new cancers after esophagogastroduodenoscopy.
Raftopoulos SC; Segarajasingam DS; Burke V; Ee HC; Yusoff IF
Am J Gastroenterol; 2010 Jun; 105(6):1292-7. PubMed ID: 20068557
[TBL] [Abstract][Full Text] [Related]
16. Interval Advanced Gastric Cancer After Negative Endoscopy.
Kim TJ; Pyo JH; Byun YH; Choi SC; Hong JP; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Lee JH
Clin Gastroenterol Hepatol; 2023 May; 21(5):1205-1213.e2. PubMed ID: 36075502
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of developing interval early gastric cancer after negative endoscopy.
Cho YS; Chung IK; Kim JH; Jung Y; Lee TH; Park SH; Kim SJ
Dig Dis Sci; 2015 Apr; 60(4):936-43. PubMed ID: 25316551
[TBL] [Abstract][Full Text] [Related]
18. How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas?
Yoo JH; Shin SJ; Lee KM; Choi JM; Wi JO; Kim DH; Lim SG; Hwang JC; Cheong JY; Yoo BM; Lee KJ; Kim JH; Cho SW
J Clin Gastroenterol; 2013 Feb; 47(2):e17-22. PubMed ID: 22810109
[TBL] [Abstract][Full Text] [Related]
19. Interval gastric cancer: A call to attentiveness and action.
Castaño-Llano R; Piñeres A; Jaramillo R; Molina S; Aristizábal F; Puerta JE
Rev Gastroenterol Mex (Engl Ed); 2023; 88(2):91-99. PubMed ID: 35659441
[TBL] [Abstract][Full Text] [Related]
20. The optimal endoscopic screening interval for detecting early gastric neoplasms.
Park CH; Kim EH; Chung H; Lee H; Park JC; Shin SK; Lee YC; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim CB; Lee SK
Gastrointest Endosc; 2014 Aug; 80(2):253-9. PubMed ID: 24613579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
